TCF4 and non-small cell lung carcinoma: In non-small cell lung cancer, DEPDC1B could enhance cell migration and invasion through the activation of Wnt/β-catenin signaling, and this biological effect could be inhibited by the depletion of LEF1 or TCF4 (Yang et al., 2014).